Max Taylor – Australian Natural Therapeutics Group (Antg)
View Detailed Executive Profile →Professional Overview
Max Taylor serves as an executive at Australian Natural Therapeutics Group (Antg), overseeing strategic initiatives and leadership responsibilities.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| National Australia Bank | Manager - Secondment | Oct 2015 – Oct 2016 |
| Deloitte Australia | Business Analyst | Jun 2008 – Jul 2011 |
| Quipmo | Co-Founder & Executive Director | Feb 2016 – Aug 2017 |
| KordaMentha | Director | Feb 2012 – Oct 2022 |
| Australian Natural Therapeutics Group (ANTG) | Chief Financial Officer | Oct 2022 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Australian Natural Therapeutics Group (Antg) corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Max Taylor's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Australian Natural Therapeutics Group (Antg)'s official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)